Novo Nordisk Launches Obesity Medicine Wegovy® (Semaglutide 2.4 mg) (MAL24126014AZ) in Malaysia
byNovo Nordisk today announced the availability of Wegovy® (semaglutide 2.4 mg) (MAL24126014AZ) in Malaysia, an adjunct treatment option for adults living with obesity and…